Distinctive HBV Replication Capacity and Susceptibility to Tenofovir Induced by a Polymerase Point Mutation in Hepatoma Cell Lines and Primary Human Hepatocytes
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Ah Ram | - |
dc.contributor.author | Cho, Ju-Yeon | - |
dc.contributor.author | Kim, Jong Chul | - |
dc.contributor.author | Dezhbord, Mehrangiz | - |
dc.contributor.author | Choo, Soo Yeun | - |
dc.contributor.author | Ahn, Chang Hyun | - |
dc.contributor.author | Kim, Na Yeon | - |
dc.contributor.author | Shin, Jae Jin | - |
dc.contributor.author | Park, Soree | - |
dc.contributor.author | Park, Eun-Sook | - |
dc.contributor.author | Won, Juhee | - |
dc.contributor.author | Kim, Dong-Sik | - |
dc.contributor.author | Lee, Jeong-Hoon | - |
dc.contributor.author | Kim, Kyun-Hwan | - |
dc.date.available | 2021-03-22T23:40:11Z | - |
dc.date.issued | 2021-02 | - |
dc.identifier.issn | 1661-6596 | - |
dc.identifier.issn | 1422-0067 | - |
dc.identifier.uri | https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/52111 | - |
dc.description.abstract | Tenofovir disoproxil fumarate (TDF) has been regarded as the most potent drug for treating patients with chronic hepatitis B (CHB). However recently, viral mutations associated with tenofovir have been reported. Here, we found a CHB patient with suboptimal response after more than 4 years of TDF treatment. Clonal analysis of hepatitis B virus (HBV) isolated from sequential sera of this patient identified the seven previously reported TDF-resistant mutations (CYELMVI). Interestingly, a threonine to alanine mutation at the 301 amino acid position of the reverse-transcriptase (RT) domain, (rtT301A), was commonly accompanied with CYELMVI at a high rate (72.7%). Since the rtT301A mutation has not been reported yet, we investigated the role of this naturally occurring mutation on the viral replication and susceptibility to tenofovir in various liver cells (hepatoma cells as well as primary human hepatocytes). A cell-based phenotypic assay revealed that the rtT301A mutation dramatically impaired the replication ability with meaningful reduction in sensitivity to tenofovir in hepatoma cell lines. However, attenuated viral replication by the rtT301A mutation was significantly restored in primary human hepatocytes (PHHs). Our findings suggest that the replication capability and drug sensitivity of HBV is different between hepatoma cell lines and PHHs. Therefore, our study emphasizes that validation studies should be performed not only in the liver cancer cell lines but also in the PHHs to understand the exact viral fitness under antiviral pressure in patients. | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Multidisciplinary Digital Publishing Institute (MDPI) | - |
dc.title | Distinctive HBV Replication Capacity and Susceptibility to Tenofovir Induced by a Polymerase Point Mutation in Hepatoma Cell Lines and Primary Human Hepatocytes | - |
dc.title.alternative | hepatitis B virus; tenofovir disoproxil fumarate (TDF); reverse transcription; nucleos(t)ide analog; drug resistance | - |
dc.type | Article | - |
dc.publisher.location | 스위스 | - |
dc.identifier.doi | 10.3390/ijms22041606 | - |
dc.identifier.scopusid | 2-s2.0-85100500461 | - |
dc.identifier.wosid | 000623814400001 | - |
dc.identifier.bibliographicCitation | International Journal of Molecular Sciences, v.22, no.4 | - |
dc.citation.title | International Journal of Molecular Sciences | - |
dc.citation.volume | 22 | - |
dc.citation.number | 4 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Multidisciplinary | - |
dc.subject.keywordPlus | B-VIRUS POLYMERASE | - |
dc.subject.keywordPlus | REVERSE-TRANSCRIPTASE DOMAIN | - |
dc.subject.keywordPlus | CHRONIC HEPATITIS-B | - |
dc.subject.keywordPlus | DISOPROXIL FUMARATE | - |
dc.subject.keywordPlus | DRUG-RESISTANCE | - |
dc.subject.keywordPlus | LAMIVUDINE | - |
dc.subject.keywordPlus | THERAPY | - |
dc.subject.keywordAuthor | hepatitis B virus | - |
dc.subject.keywordAuthor | tenofovir disoproxil fumarate (TDF) | - |
dc.subject.keywordAuthor | reverse transcription | - |
dc.subject.keywordAuthor | nucleos(t)ide analog | - |
dc.subject.keywordAuthor | drug resistance | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841)82-2-2286-1265
COPYRIGHT 2020 KOREA UNIVERSITY MEDICAL LIBRARY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.